跳至主要内容
临床试验/NCT02702167
NCT02702167终止不适用

The Dorsomedial Prefrontal Cortex as a Target in Treatment-resistant Bulimia Nervosa and Anorexia Nervosa: Investigating Target Engagement, Dosing, Reliability and Duration of Effect Using rTMS, fMRI, and a Sham Controlled Arm

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
90
试验地点
1
主要终点
Weekly Binge/Purge Frequency on Eating Disorder Examination (EDE)

研究概览

简要总结

This trial will compare the efficacy and tolerability of 10 Hz vs. 1 Hz vs. sham repetitive transcranial magnetic stimulation targeting the dorsomedial prefrontal cortex, delivered once daily over 30 days, in patients with a diagnosis of bulimia or anorexia nervosa binge-purge subtype. The trial will include structural and functional MRI, and behavioral measures obtained before, during, and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Voluntary and Competent to Consent
  • •MINI confirmed Diagnosis of Bulimia Nervosa OR Anorexia Nervosa, Binge/Purge subtype
  • •Outpatient
  • •Between the ages of 18-65
  • •Have had no increase or initiation of any psychotropic medication in the last 4 weeks prior to screening
  • •Must adhere to research schedule.
  • •Pass the TMS Safety Screening Questionnaire.
  • •Failed to achieve a clinical response to at least one pharmacotherapy or behavioral treatment in the current episode.

排除标准

  • •Have a concomitant major unstable medical illness, cardiac pacemaker or implanted medical pump
  • •Have active suicidal intent
  • •Are pregnant
  • •Have a lifetime MINI diagnosis of bipolar I or II disorder, schizophrenia, schizoaffective disorder, schizophreniform, delusional disorder, or current psychotic symptoms
  • •Have a MINI diagnosis of obsessive-compulsive disorder, post-traumatic stress disorder (current or within the last year), anxiety disorder (generalized anxiety disorder, social anxiety disorder, panic disorder), or dysthymia assessed by a study investigator to be primary and causing greater impairment than the ED
  • •Have received rTMS for any previous indication due to the potential compromise of subject blinding.

研究组 & 干预措施

High-frequency rTMS

Experimental

10 Hz repetitive transcranial magnetic stimulation to dorsomedial prefrontal cortex, once daily, 5 days per week for 6 weeks

干预措施: High-frequency rTMS (Device)

Low-frequency rTMS

Experimental

1 Hz repetitive transcranial magnetic stimulation to dorsomedial prefrontal cortex, once daily, 5 days per week for 6 weeks

干预措施: Low-frequency rTMS (Device)

Sham rTMS

Sham Comparator

Sham repetitive transcranial magnetic stimulation to dorsomedial prefrontal cortex, once daily, 5 days per week for 6 weeks

干预措施: Sham rTMS (Device)

结局指标

主要结局

Weekly Binge/Purge Frequency on Eating Disorder Examination (EDE)

时间窗: Baseline, after each week of treatment, and 1, 4, 12, and 24 weeks post-treatment

Outcome measured by a change in weekly binge and purge episodes from baseline to 2 weeks post-treatment. A 50% improvement in the score is considered a response to rTMS. A final score of 0 weekly binges and 0 weekly vomits is categorized as remission.

次要结局

  • Eating Disorder Inventory-3(Baseline, after each week of treatment, and 1, 4, 12, and 24 weeks post-treatment)
  • Eating Disorder Examination Questionnaire (EDE-Q)(Baseline, after each week of treatment, and 1, 4, 12, and 24 weeks post-treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Blake Woodside

Psychiatrist

University Health Network, Toronto

研究点 (1)

Loading locations...

相似试验